次の方法で共有

[Azure AD] – April 2017 webinars

  • [アーティクル]

Hi AAD users -

I wanted to let you know that next month webinars will start on April 4th and we have a new topic that we brought back, an updated B2B session!

 

Reminder:

  • These webinars are FREE of cost.
  • These webinars are currently held monthly with new sessions being added.
  • These session is1 hour, it includes an anonymous Q&A session with Microsoft AAD Engineering Team.

 

April webinar schedule:

NEW! Azure AD Connect Health Option 1Tuesday April 4 –7:00am PDT (UTC -7) NEW! Azure AD Connect Health Option 2Tuesday April 4 - 11:00am PDT (UTC -7) NEW! Azure AD Connect Health Option 3Tuesday April 4 - 9:00pm  PDT (UTC -7)
NEW! Azure AD Connect Health Option 4Thursday April 20 - 11:00am  PDT (UTC -7)
Secure Your Identities with Azure AD Multi Factor Authentication Option 1Wednesday April 5 - 7:00am  PDT (UTC -7) Secure Your Identities with Azure AD Multi Factor Authentication Option 2Wednesday April 5 - 11:00am  PDT (UTC -7) Secure Your Identities with Azure AD Multi Factor Authentication Option 3 Wednesday April 5 - 9:00pm  PDT (UTC -7)
Getting Ready for Azure AD Option 1Thursday April 6 - 7:00am  PDT (UTC -7) Getting Ready for Azure AD Option 2Thursday April 6 - 11:00am PDT (UTC -7) Getting Ready for Azure AD Option 3Thursday April 6 - 9:00pm  PDT (UTC -7)
Getting Ready for Azure AD Option 4Thursday April 20 - 7:00am  PDT (UTC -7)
Accessing Your Organization's Internal Application via Azure AD App Proxy Option 1Tuesday April 18 - 7:00am  PDT (UTC -7) Accessing Your Organization's Internal Application via Azure AD App Proxy Option 2Tuesday April 18 - 11:00am PDT (UTC -7)
Azure AD B2B Option 1Wednesday April 19 - 7:00am  PDT (UTC -7) Azure AD B2B Option 2Wednesday April 19 - 11:00am PDT (UTC -7)

 

Also, FYI - we recently released the Azure Active Directory Premium Deployment Wizard!

  • This wizard is designed to help you understand and deploy the key features of Azure Active Directory Premium via a user friendly interface

 

Regards,
Bea

Comments